🔎 Trials Near Me

Home › Alzheimer's Disease › NCT06840587

Connect-Home: Alzheimer's Disease and Related Dementias

Recruiting

Transitional Care for Skilled Nursing Facility Patients With Alzheimer's Disease and Related Dementias and Their Caregivers: a Cluster Randomized Trial

Who can join

Ages 19 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

Patients:

* Ability to speak English
* Goal of discharge to home, assisted living, or long-term care
* Diagnosis of dementia
* Having a caregiver willing to participate

Caregivers:

* Ability to speak English
* Legally authorized representative (LAR) who also provides support for the person with ADRD

Inclusion criteria for SNFs:

* Location within 120 miles of UNC-Chapel Hill
* Admission of at least 75 SNF patients per year

Exclusion Criteria:

Patients:

* Planned hospital readmission for procedures or treatments within 30 days post enrollment.

Caregivers:

* LAR is a court-appointed guardian.

About the study

This study is a parallel arm, cluster randomized trial (CRT) to test the efficacy of Connect-Home ADRD, a transitional care intervention focusing on Skilled Nursing Facility (SNF) patients with Alzheimer's disease and dementias and their caregivers during transitions from SNFs to home, assisted, living, and long-term care. The primary hypothesis is that the intervention will reduce caregiver strain (Aim 1) and patient neuropsychiatric symptoms (Aim 2).

What is being tested

Sponsor: University of North Carolina, Chapel Hill · Participants: 360 · Started: Apr 4, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT06840587

Locations in the U.S.

North CarolinaUniversity of North Carolina at Chapel Hill, Chapel Hill

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.